ZETA ACQUISITION CORP III 4
4 · ZETA ACQUISITION CORP III · Filed Mar 10, 2015
Insider Transaction Report
Form 4
KINLEY MATTHEW P
DirectorSecretary, CFO10% Owner
Transactions
- Disposition to Issuer
Common Stock, par value $0.0001 per share
2015-03-06−2,000,000→ 0 total
Footnotes (1)
- [F1]On March 6, 2015, Kura Oncology, Inc. (formerly Zeta Acquisition Corp. III) (the "Issuer") and the stockholders of the Issuer (the "Sellers") entered into a Redemption Agreement (the "Agreement"). Pursuant to the Agreement, the Issuer re-purchased and redeemed from Mr. Kinley 2,000,000 shares of Common Stock (the "Shares") for a purchase price equal to twenty-eight thousand dollars ($28,000). The purchase and sale of the Shares took place at a closing on March 6, 2015 immediately following the effectiveness of the merger transaction (the "Merger") contemplated by the Agreement and Plan of Merger, dated March 6, 2015, among the Issuer, Kura Oncology, Inc, and Kura Operations, Inc., a wholly-owned subsidiary of the Issuer.